Skip to main content

Table 3 Genetic alterations in Ollier chondrosarcomas

From: Genome-wide analysis of Ollier disease: Is it all in the genes?

Sample Tumor Grade Gain Loss LOH Copy neutral LOH
L2218 CS I - - - -
L204 CS I 1q 3p,4q 3p,4q -
L253 CS I 1q 6p,6q,9p,12q,13 6p,6q,9p,12q,13 -
L1977 CS I - - - -
L1685 CS I - 2q 2q -
L1687 CS I 3p,7q,8q - - -
L2386 CS I - 6p,11q - -
L2103b CS I - - - -
L2221 CS I 14q,17q - - -
L1513 CS I - - - -
L2280 CS I - - - -
L2513 CS I - - - -
L286 CS II 5p,11p,11q,18p 3p,5p,5q,6q,9p,11p,18p,18q 3p,5p,6q,9p,11p,18p,18q -
L1976 CS II 8q - 8q -
L2098 CS II 2,5,7,15,16,17q,18,20,21 10,17q 10,17q 11
L2099 CS II - - - -
L810 CS III - 4,5q,6q,9p,12p,13,14q 4,5q,6q,9p,12p,13,14q -
L2104a CS III 1q,2p,2q,12p,14q 3q,5q,7q,9p,12p, 22 3q,5q,7q,9p,12p,22 2q
  1. Some of the regions with loss do not show loss of heterozygosity (LOH). This could be explained by the loss of alleles in an aneuploid background.